As a transcriptional regulator, RUNX1 promotes the malignant progression of Mes GBM by significantly affecting the expression of oncogenes and tumor suppressor genes in a TGFβ pathway-dependent manner. This evidence concerns the gene RUNX1 and glioblastoma.